| Name | Title | Contact Details |
|---|
Beacon Futures Inc is a Bonita Springs, FL-based company in the Business Services sector.
Press Colorcom is a Santa Fe Springs, CA-based company in the Business Services sector.
Beyeonics is all about empowering surgeons with OR surgical digital consolidating platforms using enhanced imaging, advanced data processing, AI, and surgical navigation technologies that are all naturally displayed and controlled through an immersive Augmented Reality Surgical Headset. We introduce innovation to healthcare with surgeon-centric surgical platforms originally developed by a leading global aviation company for pilots. Technologies that now serve us to address the present and future surgical needs in Ophthalmology. We believe in and practice innovation, commitment, and performance to drive our technologies to fulfillment and invest in our Beyeonics human power teams to meet our long-term cause. Beyeonics represents a group of medical technology companies executing our mission. Beyeonics Vision Ltd is a medical technology company dedicated to developing and commercially introducing our surgeons empowering platform technologies to various clinical specialties.
Blitz Models & Talents is a Toronto, ON-based company in the Business Services sector.
Viridian Therapeutics, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2006. Formerly known as Miragen Therapeutics, the company rebranded in January 2021. Viridian is dedicated to discovering, developing, and commercializing treatments for serious and rare diseases, utilizing its expertise in antibody discovery and protein engineering. The company’s product pipeline includes Veligrotug (VRDN-001), a monoclonal antibody in Phase 3 clinical trials for thyroid eye disease, and VRDN-003, a next-generation IGF-1R monoclonal antibody also in Phase 3 trials for the same condition. Additionally, Viridian is developing a portfolio of engineered anti-FcRn inhibitors, such as VRDN-006 and VRDN-008, aimed at treating various autoimmune diseases. Viridians mission is to deliver transformative therapies for patients with underserved diseases, emphasizing innovation and patient-centricity.